MIT Technology Review Subscribe

Personal Genomes

Individual sequencing could be around the corner.

The Human Genome Project’s working draft sequence, which was completed to much fanfare in June 2000, took about a dozen years and more than $300 million to complete. The result was a composite map of the DNA from several people-a sort of averaged genetic picture of a human. But a growing number of companies are working on advanced technologies that could make it possible to have your own individual genome sequenced in a day, perhaps for as little as a few thousand dollars.

No one’s genetic makeup matches “the human genome” exactly; the differences are what give one person brown eyes and another blue or make some people more susceptible to heart disease. The new technologies could give anyone access to the unique, letter-by-letter sequence of his or her entire genome and help doctors detect the variations that signal health problems down the road.

Advertisement

Today’s sequencing methods are costly and slow in part because for each DNA letter read-of the roughly three billion in a human genome-researchers need to synthesize a separate copy of the DNA strand. Making the copies requires several chemical reactions; then you have to separate and identify the newly made strands. In contrast, two new techniques being developed could read the sequence directly from one DNA molecule. The first method, called “nanopore sequencing,” involves pushing a strand of DNA through a tiny hole surrounded by sensors that detect the electrical changes caused by each DNA letter. The second takes advantage of an enzyme called DNA polymerase, which copies DNA inside our cells. Researchers use specialized optics to detect each letter added as the enzyme copies the original DNA strand.

This story is only available to subscribers.

Don’t settle for half the story.
Get paywall-free access to technology news for the here and now.

Subscribe now Already a subscriber? Sign in
You’ve read all your free stories.

MIT Technology Review provides an intelligent and independent filter for the flood of information about technology.

Subscribe now Already a subscriber? Sign in

In May, Palo Alto, CA-based Agilent Technologies signed an agreement with Harvard researchers Daniel Branton and Jene Golovchenko to further develop nanopore sequencing, which Branton coinvented (see “Hole in the Wall Offers Cheaper Sequencing,” TR May/June 1998). Also this year, Woburn, MA-based U.S. Genomics received its first patents on technologies that combine the two direct techniques. Thanks to these and several other efforts (see table), the dream of sequencing a human genome in just a day could be a reality in two to five years, says George Weinstock, codirector of the Baylor College of Medicine Human Genome Sequencing Center in Houston. “They’re all very clever techniques,” he says. “We’re getting very close to having them in hand.”

Though the new sequencing tools will initially be used for biomedical research, they could eventually find their way into doctors’ offices, not only providing for quick gene-based diagnosis of a host of diseases, but also helping doctors choose medicines tailored to individual patients. The expected price tag to sequence your genome-perhaps $5,000 to $30,000-might seem steep, but “it’s kind of a life investment,” says Harvard Medical School biophysicist George Church. “I would pay $10,000 to get my genome sequencedrather than buying a second car.”

This is your last free story.
Sign in Subscribe now

Your daily newsletter about what’s up in emerging technology from MIT Technology Review.

Please, enter a valid email.
Privacy Policy
Submitting...
There was an error submitting the request.
Thanks for signing up!

Our most popular stories

Advertisement